[The antineoplastic effect of violamycins and lambdamycin in experimental leukemias].
D000617:Aminoglycosides / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001578:Benzopyrans; D004305:Dose-Response Relationship, Drug; D006027:Glycosides / Q000627:therapeutic use*; D007939:Leukemia L1210 / Q000188:drug therapy; D007941:Leukemia P388 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy*; D009115:Muridae
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001578:Benzopyrans; D006027:Glycosides; C010806:violamycins; C002185:chartreusin
Uber die antieoplastische Wirksamkeit von Violamycinen und Lambdamycin gegen experimentelle Leukämien.